We use noninvasive data (body surface potential mapping, BSPM) to personalize the main parameters of a cardiac electrophysiological (EP) model for predicting the response to different pacing conditions. Methods: First, an efficient forward model is proposed, coupling the Mitchell-Schaeffer transmembrane potential model with a current dipole formulation. Then, we estimate the main parameters of the cardiac model: activation onset location and tissue conductivity. A large patient-specific database of simulated BSPM is generated, from which specific features are extracted to train a machine learning algorithm. The activation onset location is computed from a Kernel Ridge Regression and a second regression calibrates the global ventricular conductivity. Results: The evaluation of the results is done both on a benchmark dataset of a patient with premature ventricular contraction (PVC) and on five nonischaemic implanted cardiac resynchonization therapy (CRT) patients with a total of 21 different pacing conditions. Good personalization results were found in terms of the activation onset location for the PVC (mean distance error, MDE = 20.3 mm), for the pacing sites (MDE = 21.7 mm) and for the CRT patients (MDE = 24.6 mm). We tested the predictive power of the personalized model for biventricular pacing and showed that we could predict the new electrical activity patterns with a good accuracy in terms of BSPM signals. Conclusion: We have personalized the cardiac EP model and predicted new patient-specific pacing conditions. Significance: This is an encouraging first step towards a noninvasive preoperative prediction of the response to different pacing conditions to assist clinicians for CRT patient selection and therapy planning.
I. INTRODUCTION

H
EART Failure (HF) is a major health issue in Europe affecting six million patients and growing substantially because of the ageing population and improving survival following myocardial infarction. The poor short to medium term prognosis of these patients means that treatments such as cardiac resynchronization therapy can have substantial impact [1] . However, these therapies are ineffective in 30% of the treated patients and involve significant morbidity and substantial cost. To this end, the precise understanding of the patientspecific cardiac function can help predict the response to therapy and therefore select the potential candidates and optimise the therapy.
In [2] , Sermesant et al. proposed to personalize an electromechanical model of the heart to predict the response to CRT. The method requires to measure intracardiac electrical potentials through an invasive endovascular procedure which can be risky for the patient, and which is not suitable at a patient selection stage. The aim of this article is to extend this approach to noninvasive body surface potential mapping (BSPM), which uses up to 256 sensors on both sides of the torso, as the CardioInsight 1 jacket now commercially available. This has the potential to replace invasive measurements however the ability to estimate parameters and predict activation from such data still needs to be evaluated.
A. Cardiac EP Model Personalization
Restricting our study to the ventricles, there are several types of EP models describing the action potential [3] ; from complex ones (biophysical models) to very simplistic ones (Eikonal models). In this study we used the Mitchell-Schaeffer model [4] that is a phenomenological model of intermediate complexity with two variables and six parameters with a biophysical interpretation. From an onset activation location, the evolution of the transmembrane potential is computed at each node of a tetrahedral mesh of the myocardium using the finite element method.
The estimation of patient-specific parameters of a cardiac EP model is crucial for understanding of pathologies and predicting the response to therapies. The model personalization usually 1 ECVUE, CardioInsight Technologies Inc., Cleveland, Ohio.
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deals with local parameters. Relanet et al. [5] used optical mapping in an ex-vivo study to evaluate such algorithms. Personalization using intracardiac potential mapping was investigated by Relan et al. [6] , Wallman et al. [7] , and Konukoglu et al. [8] , also including epicardial recordings. Calibration using noninvasive data was recently studied: Dössel et al. [9] adjusted two parameters of an atrial EP model using BSPM data. Zettinig et al. [10] used two features from the 12-lead ECG to recover three electrical diffusivity parameters using a polynomial regression. The method is novel and efficient, but it suffers from the fact that the earliest activation site was fixed but actually unknown, and only two features (QRS duration and electrical axis) may not be sufficient to describe the cardiac activation. Such approaches have explored the use of machine learning for EP personalization, but as no patient-specific database exists, they can only rely on simulated patient-specific samples covering the parameter space. In terms of personalization methodology, the work in [8] is based on an inference method combining polynomial chaos and compressed sensing, the work in [10] employs polynomial regression into a statistical framework, and the work in [7] relies on a Bayesian inference model.
B. Forward Problem of Electrocardiography
The estimation of the ECG data from the cardiac potentials is usually called the forward problem of electrocardiography (in opposition to the inverse problem, see Section I-C). The two classical numerical approaches are based either on the Boundary Element Method (BEM) or the Finite Element Method (FEM). They both propagate the epicardial heart action potentials to the surface of the body by taking into account the distance, the null current across the body surface, and the different properties of the tissues in between. Forward models differ also by their incorporation of heterogeneous conductivity regions associated with various organs within the torso. By taking into account the physical properties of the different tissues, the computed ECG account for more complex current pathways. In [11] , Keller et al. demonstrates the importance of the torso inhomogeneity by ranking the influence of the different tissue conductivities on forward-calculated ECGs. Ramanathan et al. [12] showed, however, that at a first order approximation the torso inhomogeneities are not necessary for noninvasive reconstructions. Some techniques rely neither on BEM nor on FEM and assume a homogeneous and infinite torso domain using a dipole formulation [13] . While neglecting some the null current flow constraint at the body surface, it has been shown to be efficient on in-silico experiments.
C. Inverse Problem of Electrocardiography
BSPM data has been widely used in the last decades to directly compute the cardiac action potentials by solving an illposed inverse problem: finding the transfer matrix linking the torso potentials to the cardiac potential sources [14] . If most of the methods are only estimating the potential on the surface of the heart (e.g., [15] , [16] ), transmural-based methods have been investigated in the last few years but are computationally more demanding [17] , [18] . Rather than estimating directly the transmembrane potentials, the 3DCEI technique [19] - [22] solves the inverse problem by estimating the equivalent current density. Aside from standard regularization techniques, some inverse problem studies have been investigated imposing constraints in temporal and spatial domains [17] , [23] or trying to take advantage of the space/time coupling of the electrical wave propagation [13] , [24] . Some methods are also looking into integrating physiological and model-based priors in a Bayesian framework [25] , [26] . Li and He [27] solved the inverse problem by means of heart-model parameters (onset activation location) and was further extended [28] and validated on rabbits [29] , and swines [30] , [31] . A preliminary step is based on a priori knowledge using artificial neural network and an optimization algorithm refines the parameters. Electrographic imaging (ECGI) is already is commercially available, as the CardioInsight Technologies software [32] which was also used in recent ECGI studies [33] . ECGI can help in understanding dyssynchony and selecting CRT candidates: Varma et al. [34] and Ghosh et al. [35] worked on characterizing the EP substrate and electrical dyssynchony on HF patients undergoing CRT while Dawoud et al. [36] investigated regional electromechanical uncoupling in patients referred for CRT.
D. Proposed Approach
Our method is based on adjusting a forward model to measured BSPM in order to estimate patient-specific parameters and activation maps. Our personalization involves identifying the parameters to predict new patient-specific pacing conditions. In order to avoid local minima we used a machine learning approach with the generation of a large patient-specific database of simulated BSPM. Some relevant shape descriptors were extracted from the simulated BSPM and used as patient-specific training set. We first learned the onset activation location using a Kernel Ridge Regression on activation maps, then use a second regression to calibrate the global ventricular conduction velocity (CV). Because the onset activation is a local parameter, this method can be associated with a model personalization. Our contributions are 1) A two-step algorithm that learns the parameters of the simulation by estimating the onset activation location and the global CV. The algorithm relies on machine learning approaches based on a few QRS shape-related features extracted from each BSPM sensor. 2) A straightforward and efficient coupled forward model based on the Mitchell-Schaeffer model and on a current dipole formulation, allowing to simultaneously calculate transmural cardiac potentials and BSPMs. The Mitchell-Schaeffer model previously showed good predictive power in intra-cardiac studies [37] . . Using patient-specific training sets, the two-step personalization (see Section II-C) based on machine learning techinques estimates the earliest activation location and the global CV from univentricular pacings or ectopic foci. The true location of the pacing lead is used for evaluation. A prediction of biventricular pacings (see Section III-C) is performed using estimated parameters from sinus rhythm personalization.
settings from 5 patients. Predicted BSPM are compared with measured BSPM. 5) A quantification on the impact of myocardial geometry quality and scar tissue, and an extension of our method to standard 12-lead ECG data.
E. Outline of the Manuscript
In the following Section II, we will present our personalization framework (see Fig. 1 ): clinical data, forward EP model, and machine learning algorithm. Section III is dedicated to two evaluations on different datasets and to predictions of biventricular pacing. Finally, Section IV discusses different aspects of the method, related in particular to the robustness and to the influence of the myocardial geometry and scar tissue.
II. MATERIALS AND METHODS
A. Clinical Data
In this study, two datasets with different devices were used. The pacing lead is either at the tip of a moving catheter on the LV cavity or from a pacemaker device. The BSPM potentials were acquired during the procedure at a sampling rate of 1 kHz, with different number of torso sensors depending on the device. The anatomy as well as the location of the torso sensors and the pacing leads were extracted either with imaging (Magnetic Resonance Imaging (MRI) or CT scanner) or through the EP mapping system using magnetic sensors. Fibre orientations were estimated with a rule-based method (elevation angle between −60
• to 60 • ). More details on the data will be provided in Sections III-A1 and III-B1.
B. Simulating BSPM Data: EP Forward Model
1) Mitchell-Schaeffer Cardiac Model:
We simulated the electrical activation of the heart using the monodomain version of the Mitchell-Schaeffer's EP model [4] . It has two variables, the transmembrane potential v and z a secondary variable controlling the repolarization phase. Their evolution is governed by
The parameters τ open and τ close define the gate opening and closing depending on the change-over voltage v gate , and the parameters τ in and τ out control the depolarization upstroke and repolarization downstroke. The diffusion term is defined by an 
2) From Cardiac Simulations to BSPM, Current Dipole Formulation:
We can compute simultaneously the cardiac electrical sources simulated in Section II-B1 and the BSPM. As in [13] , we modeled every myocardium volume element (tetrahedron) as a spatially fixed but time varying current dipole. We define the equivalent current density j eq as
j eq is a current dipole moment per unit of volume and the local dipole moment p in the volume V writes as p = V j eq dV . The torso is composed of different organs that behave as different volume conductors. In a rough approximation, we consider an homogeneous, infinite volume of conductivity σ T , and we took σ T = 0.2 S/m. According to the volume conductor theory [39] , the electric potential at a distance R in a homogeneous volume conductor of conductivity σ T is
We model the moving propagation front as a dipole field. The infinitesimal dipole moment of the volume dV X located at position X is defined as p X = j eq,X dV X = −σ i X ∇v X dV X . As we use linear tetrahedra in the FEM discretization of the myocardium, the potential v is linear and ∇v is constant over the tetrahedron. We get the following formulation of the dipole moment of the charge in the volume V H of tetrahedron H of the myocardial mesh:
The gradient of the electric potential ∇v H for a tetrahedron H is estimated using the node positions X k H and the shape vectors
where
The gradient of the electric potential in the tetrahedron H is then computed from the potentials
From (3), the contribution Ψ H of the tetrahedron H to the potential field calculated at position X T is
with − − → HT the vector from centre of the tetrahedron H to the torso electrode location T . Finally, we sum over the whole mesh to get the potential field at X T .
The implementation was done using the SOFA platform, 2 with a direct coupling to the Mitchell-Schaeffer model. For a generic volumetric mesh of 65 000 vertices, every coupled simulation (cardiac model and dipole formulation) of 300 ms runs in less than 6 min, with a time step of 0.01 ms (using a dualXeon X5670 with 12 cores at 2.93 GHz). With GPU version of the implementation [41] , the simulation was performed in 2 min (using a dual-Xeon X5650 and a Tesla C2050 with 112 cores at 1.147 GHz).
3) Comparison of the Current Dipole Results
With BEM: while being straightforward and efficient, this method includes some simplifications as the absence of a null current flow constraint at the body surface. To validate and estimate the errors of our forward model, we compared our results with a classical BEM forward formulation. We used the symmetric BEM from the OpenMEEG software 3 because it was shown to provide an excellent accuracy [42] . As input, the isolated dipole source were set at the center of each tetrahedra on the myocardium and calculated the vector sources of each tetrahedron at each time using (2) . We defined 3 domains: the myocardium, the torso and the air outside the torso (null conductivity). Their interfaces were defined using closed surface meshes. The linear operator L which associates dipolar sources to the resulting sensor measurements is calculated by solving L = S G −1 D, where D is the dipole matrix, S is the sensor matrix, and G is the geometry matrix. With a torso surface mesh of 4K vertices, a heart surface mesh of 7K, 75K dipolar sources and 52 sensors, the L matrix is computed in 7 h. As an example, the potentials at four random sensor locations simulated with OpenMEEG (blue) and our dipole formulation (red) are shown in Fig. 2 . In some surface potentials the OpenMEEG ECG has larger amplitude as on b and c, whereas on some other the amplitude is lower as on a and d. The difference is due to the absence of boundary conditions in our formulation. A key point to notice is that the signal shape and sign are similar, while reducing the computation time from 7 h to a few minutes.
C. Personalising a Cardiac EP Model From BSPM
1) Two-
Step Machine Learning-Based Personalization: The two machine learning algorithms are two different regressions, both using simulated patient-specific data as training sets. For the first step, a Kernel Ridge Regression is estimating the onset activation location. From 250 random onset activation locations, their respective activation maps are simulated together with their simulated BSPM. After a feature extraction on both the measured and the simulated BSPM, the Kernel Ridge Regression estimates the cardiac activation time corresponding to the measured BSPM on each node of the cardiac mesh from the cardiac activation times of the simulated BSPM with the closest features. The onset location is identified as the node with the smallest activation time. During the second step, 100 CV values and their simulated BSPMs are used as a training set for a two-term exponential regression. Once the unknowns of the regression function are estimated, the CV of the true signal is estimated (see Fig. 1 ).
2) BSPM Feature Description: Important aspects of the torso electrical signal are the shape, the timing, and the sign of the QRS complex. Because the reference electrode is often not localized, each signal (measured and simulated) was first subtracted by the mean BSPM signal (measured or simulated). Then, each signal (measured or simulated) was normalized and smoothed with a local Gaussian filter. We then defined 7 × n s descriptors (n s being the number of sensors in the jacket) of the QRS window as (see Fig. 3 ): (1) timing of the global extremum, (2) absolute potential of the global extremum, (3) sign the global extremum, (4) number of zero crossings, (5) number of local extrema, (6) relative algebraic area, and (7) sign of the first extremum. This choice was inspired by previous works on ECG analysis, e.g., [43] .
3) First Step, Locate the Activation Onset With Kernel Ridge Regression: The shape of the measured torso signals strongly depends on the position of the onset activation. The first step of the noninvasive cardiac model personalization is an automatic estimation of the onset activation site on the cardiac mesh. From a list of 250 random nodes on the surface of the cardiac mesh (epicardium and endocardium), we simulated a set of activation maps and corresponding BSPM. We fixed the global ventricular CV to a nominal value of 0.5 m.s −1 and we only used the six features that are invariant to a small change of the global CV (i.e., we excluded the timing of the global extremum). The training feature database was normalized along each feature. We used a Kernel Ridge Regression between features extracted from the BSPM to predict the activation time on each node of the cardiac mesh. A Ridge Regression is a regularized least square method which is suited for a reasonable number of training examples. The kernel trick is useful here because the number of features (roughly 1500) is larger than the number of samples (250). We simulated a database composed of 250 couples (x i , y i ) of feature vectors x i and corresponding depolarization time vectors y i . The predicted target y for a new test point x was estimated using
where y is the matrix of the sampled targets
is a Gaussian kernel of bandwidth σ, and the ith coordinate of the vector κ(x) is defined as (κ(x)) i = K(x i , x). γ is the coefficient balancing the smoothness and the adherence to the data. The tuning of σ and γ was performed by a tenfold cross validation. The same values were used for other patients. For each couple of parameters (σ, γ) the mean distance to the synthetic onset location is plotted in Fig. 4(a) . It represents the error, since a perfect initial position estimate would result in a null distance. The estimated prediction error is 5.7 mm for the couple (σ = 10 3.5 , γ = 10). We notice that the value of σ is of the same order of magnitude as the size of the feature vector x i . This is coherent, because each component of x i belongs to a distribution with unitary standard deviation, so the distance between x i and x j is also of the order of their size. Fig. 4(b) shows the distance error to the true pacing location for a clinical case when varying dataset size (result unchanged after 200 samples).
4) Second
Step, Estimate the Ventricular Cardiac CV With Two-Term Exponential Regression: The previous estimation of the onset location allowed us to further calibrate the EP model. We modeled the ventricles as an homogeneous tissue with a uniform CV that we want to estimate. We randomly sample 100 CV in the range [0.2, 1.5] m.s −1 . We generated the corresponding personalized BSPM database with fixed onset location. We extracted from the simulated BSPM one type of feature directly related to the CV: the position of the global extremum. The size of one feature vector is thus 1 × n s , and the database was composed of 100 couples (x i , y i ) of feature vectors x i , and corresponding CV parameters y i . The predicted target y for a new test point x was estimated by a regression between the first mode of the PCA of the training feature vectors X 1,i and the conduction velocities y i . The estimated function f (X 1 ) = y was fitted using a two-term exponential regression f (x) = ae bx + ce dx . Step. Example for one patient and one pacing. Twoterm exponential regression using the first principal component with automatic exclusion of outliers (small conductivities). The red star is the measured BSPM projection.
In some cases, a too small conductivity can make the extremum of the signal exceed the QRS time frame; so the corresponding samples were automatically excluded. Finally, the measured BSPM can be projected into the PCA space and the CV is estimated from the regression (see Fig. 5 ).
5) Iterating and Final Simulation Using Estimated Parameters:
Step 1 and 2 are then iterated until convergence (Δc < 0.05 m/s). The final step consists in rerunning the EP model during one cardiac cycle using the estimated onset location and the estimated global CV. The final result consists in a transmural activation map, where the depolarization times are computed at each node of the mesh. In addition we simulate the corresponding BSPM. An estimation of the result confidence is given by the averaged correlation coefficient (CC) between the simulated and measured BSPM.
III. PERSONALIZATION EXPERIMENTS AND RESULTS
A. Evaluation on PVC Benchmark Clinical Dataset
1) BSPM and Intracardiac Acquisitions:
We tested our method on a benchmark study of the ECGI community which provides clinical data from 63 BSPM electrodes on one nonischaemic patient recorded during an Premature Ventricular Contraction (PVC) ablation procedure. Ventricularly paced beats from a catheter were also recorded. The dataset 4 includes the geometry of the myocardium, the location of the 63 torso electrodes and the 7 pacing sites, as well as an estimation of the PVC site, see Fig. 6 . For the PVC ground truth, both the earliest measured local activation time measured by intracardiac CARTO system and the latest successful ablation site were recorded: they do not match but they both give an indication about the real PVC location. The BSPMs consist in several QRS time windows at a sampling rate of 1 kHz. The QRS without pacing (marked as 'PVC') was recorded 10 times (10 runs), while for the 7 pacing sites the number of runs varies from 1 to 14. A volumetric myocardial mesh of roughly 10K elements was created from the provided surface mesh using the 
CGAL
5 meshing software, and fibre directions were estimated (see Section II-A).
2) Results for PVC and Pacing Sites Localization: Our personalization pipeline was launched for every run, and we compared the localization errors with those of the inverse method of [44] . Fig. 7 (a) presents the error distances for the PVC (mean distance error or MDE = 20.3 mm) and for seven catheter pacing locations (MDE = 21.69 mm among all pacings). The error distances have to be compared to the distance of the measured excitation onset point to the closest point of the mesh (11.8 mm for the PVC, pink dotted line), showing that the registration between the intra catheter localization and the preoperative imaging is not very accurate. From Fig. 7(a) , our personalization method provides results comparable to other state-of-the art inverse problem methods like [44] , with better results for a majority of pacing sites locations. Global CV for all PVC runs was found in the range [0.33, 0.38] m/s. Looking at Fig. 7(b) and (c), the estimated PVC location is found to be close to the location of the earliest activation time measured and the latest successful ablation site lying in the aorta. The former was measured by catheter, while the latter is the location where the ablation procedure succeeded.
B. Evaluation on Five Implanted CRT Patients
1) BSPM Acquisitions With CardioInsight Jackets:
The second dataset was acquired at St Thomas' Hospital, London. The CardioInsight jacket is able to acquire simultaneously 256 signals on the torso surface. The dataset consists of five patients, all being implanted CRT patients and nonischaemic. In the optimization procedure, the cardiologists performs several recordings corresponding to different pacing combinations and delays between the right ventricle (RV pacing, endocardial) and the left ventricle (LV pacing, epicardial) pacing leads. In total, 114 different settings were recorded. For all patients, an LV pacing and an RV pacing were performed, together with several biventricular pacings where the two stimulations are either simultaneous or separated by a delay. A sinus rhythm sequence is also recorded on patients that do not have complete heart blocks, see Table I . The QRS time window was recorded at a sampling rate of 1 kHz. From the information given on the state of every sensor (good, disconnected, missing, bad), the nonreliable sensors of each recording was removed. The number of sensors used in our personalization varied between 175 and 220. The relative position of electrodes and pacing sites with respect to an epicardial geometry were hand-extracted from a CT scanner performed the day of the intervention (see Fig. 8 ). Important artifacts on the CT scanner coming from the pacemaker prevents creating a better segmentation. The CardioInsight Technologies software is solving the inverse problem on this epicardial surface. The method estimates the epicardial potentials based on the standard formulation using a Tikhonov regularization and the generalized minimal residual algorithm [32] . Clinicians can use the activation maps from the CardioInsight software for diagnosis or therapy planning. In this work, we used these activation maps to evaluate our personalization algorithm.
For patient 5 the precise geometry of the heart was extracted using MRI, allowing us to segment properly the myocardium. In addition, delayed contrast enhancement MRI (DCE-MRI) was also acquired and a scar region was segmented [patient 5 has a nonischaemic cardiomyopathy (NICM)]. The other patients with recorded BSPM did not undergo MRI as they were already implanted (see Table I ). We used this patient to evaluate the effects of the precise myocardium geometry and the presence of scar tissue.
2) Preprocessing: For Patient 5, the myocardial mesh was generated using the VP2HF 6 platform and the VP2HF meshing pipeline [45] creating a tetrahedral mesh with roughly 150K elements. The scar was semiautomatically segmented by a clinician and registered to the myocardial mesh. We imposed the scar tissue to have no reaction term in the Mitchell-Schaeffer model by setting much higher values of τ in and τ out [cf. (1) ] and a small CV of 0.2 m/s. We manually rigidly registered this volumetric mesh to the epicardial surface extracted from the CT scanner. For other patients, as no precise geometry was available a generic volumetric myocardial mesh of roughly 65K tetrahedra was manually registered to the CT image. Even if the shape of the myocardium is generic, its orientation, its position, and its size is patient-specific. 3) Error on Onset Activation Location: Fig. 9 shows for the five patients the Euclidean distance between the onset activation location and the true pacing lead. For all patients, three iterations were necessary and the mean improvement in terms of localization error was 2 mm. The CardioInsight onset location is constrained to lie on the CardioInsight epicardial mesh whereas our method constrain it to lie on the volumetric mesh (but often generic), so both models include geometry uncertainties. The MDE for both LV and RV pacings were found at 24.6(std = 11.9) mm for our personalization results, and 39.3(std = 15.8) mm for the CardioInsight inverse solution. Patient 2 has very poor data quality (obese person with 20% of torso sensors disconnected and located in the sensitive zone) explaining the poor result in terms of localization by the personalization (43 mm for RV/LV) as well as by CardioInsight (RV:62 mm, LV:52 mm).
4) Results on CV:
The estimated CV could not be quantitatively evaluated because the ground truth is not available but we can look at the coherence between several acquisitions with different pacing conditions for the same patient. Fig. 10 shows the CV values for the sinus rhythm, the LV pacing, and the RV pacing. We can see that based on a broad range of possible values (uniformly in [0.2,1.5] m/s), all CVs lie within a clinically acceptable range ([0.29,0.62] m/s) [46] . Moreover, the global CV found with different pacing locations on the same patient are usually in good agreement. Fig. 11(a), (c) , and (e)shows for Patient 5 the estimated transmural activation maps obtained after our personalization for the sinus rhythm, the RV pacing and the LV pacing. The red dot indicates the true pacing lead position as segmented from the CT scanner. The early activation zones were found near the true pacing lead. We are also showing the CardioInsight epicardial solution [see Fig. 11(b), (d), and (f) ]. If the comparison shows a good agreement, on this case our personalization gives a more precise solution. For example, we can see that the sinus rhythm onset was found on the septum, which is not visible in the CardioInsight solution.
5) Comparison of the Estimated Activation Maps:
6) Results in Terms of BSPM Signals:
The simulated and the measured BSPMs of patient 5 are represented in Fig. 12 for six sensors uniformly chosen. The simulated BSPM has been scaled by its total norm and multiplied by the measured BSPM total norm. We calculated for each recording the averaged CC between measured and estimated BSPM. We can see a good agreement for the RV pacing and the LV pacing, while the signals of the sinus rhythm are more difficult to reproduce for this patient (CC = 0.32). It may be due to the fact that this sinus rhythm sequence is complex (presence of scar, possibly multiple onsets). For the two other sinus rhythm personalizations (patients 1 and 2) we found a better agreement with a CC of 0.58 and 0.62. Fig. 13 depicts the evolution of the estimated signal during the different steps of our personalization for the RV pacing. The averaged CC is improved after each step (from −0.15 to 0.83).
C. Prediction of Stimulation Results From Personalized Model
While our approach does provide an activation map of the myocardium, the main aim of this personalization is to benefit from the predictive power of the underlying forward model. We therefore tested in this section how well the personalized models could predict different pacing conditions. To this end, we used the CV results of our personalization from the sinus rhythm (estimated in Section III-B4) to simulate biventricular pacing (when the sinus rhythm was not available, we took the mean of the LV pacing and RV pacing). In the clinical procedure several types of biventricular pacings were tested by changing the timing 
IV. DISCUSSION
A. Personalization Using 12-Lead ECG Data
From the BSPM electrodes of the CRT dataset, we extracted for each patient 9 electrodes roughly located at conventional ECG placement in order to derive the 12-lead ECG (see Fig. 15 ). The derivations were performed on the simulated and on the ground truth signals. We applied our personalization for the 12-lead ECG data to the five CRT patients. The MDE was 29.8 mm, which is higher than the BSPM personalization (24.6 mm). However, by looking closely at the results, the errors were particularly important on patient 2 (RV lead: 57 mm, LV lead: 64 mm), while small errors were obtained on patient 5 (RV lead: 10 mm, LV lead: 12 mm). Knowing that the data from patient 2 was of very poor quality and that patient 5 is the only one having a personalised geometry, the 12-lead ECG may be less robust than BSPM personalization. The fact that the location was well located on cases with correct data quality seems to show that our method is sufficiently constrained such as to work with few signals.
B. Quantifying the Impact of a Precise Myocardial Geometry
Only the data from Patient 5 of the CRT database included MRI and thus allowing a precise myocardial segmentation. For other patients, a generic heart mesh was rigidly registered and scaled to the myocardial shape from a CT scanner with important artifacts. In this section we want to quantify the impact of a precise myocardial geometry to our personalization results in terms of onset location and errors on BSPM. The results of patient 5 using the MRI segmentation were compared to the results using the generic heart manually rigidly registered and scaled to the same location. Since Patient 5 has a scar segmentation available (see Section III-B2), the scar region was also mapped to the generic heart mesh. From Fig. 17 , the onset location was found to be less accurate with the generic mesh for the LV pacing (error is 43.4 mm for the generic heart, 13.7 mm for the MRI segmentation) as well as for the RV pacing (24.3 mm for the generic heart, 16.0 mm for the MRI segmentation). The activation map using the generic mesh for the LV pacing can be seen in Fig. 16(b) . We can notice that the estimated onset locations using a generic heart are still in an acceptable error range. We can conclude that a patient-specific geometry leads to a more accurate personalization while the use of a generic mesh is still a fair approximation on this case.
C. Modelling Scar Tissue: Its Impact on Our Personalization
The six patients from both datasets were identified as nonischaemic. However, patient 5 has an NICM with an annotated scar from DCE-MRI. In the presence of scar tissues we suppress the reaction term in the Mitchell-Schaeffer model and reduce the conductivity of the tissues to 0.2 m/s. In order to measure the impact of a scar on the personalization process, we compared in Fig. 17 the precision obtained with and without the scar information. We can see that including the scar information yields better results for the LV pacing, where the pacing lead is closer to the scar region (see Fig. 16(c) for the estimated activation map). By incorporating some structural information, we were able to improve the personalization results. However, as the scar information is not always available we believe that it could be learned directly through the personalization process, by detecting regions where the conductivity has to be locally reduced.
D. Future Works
We have been estimating the parameters of singular pacing sites and predicting the response to multiple pacings. We are now interested in extending the study to the estimation of the location of more than one activation site, and we believe it would only require more computation time for increasing the training database. A future goal is to help the clinicians in predicting the best combination and the best lead locations among the possible and reachable zones before the implantation. Swenson et al. [47] reveal the importance of the cardiac position in the ECG forward problem, we believe that a more precise registration of the myocardial mesh to the CT scanner would have a positive impact. Finally, in this study we did not include a Purkinje system model as most of the patients have bundle branch blocks, but we believe it to be an important improvement. To account for more drastic variations of onset and conductivities, we may also reconsider the methodology as the use of advanced nonlinear dimensionality reduction techniques. Even if the current difficulty of the personalization is to understand and model to complex pathologies, we do think that it could help the analysis of ECGI because the problem is more physiologically constrained.
V. CONCLUSION
From noninvasive measures including BSPM signals, we were able to personalize the location of the onset activation location and the global CV of the myocardium with a two-step algorithm. We built a large database of simulated BSPM in order to train a machine learning algorithm based on a few QRS shaperelated features from each BSPM sensor. The simulated BSPM relies on a transmural forward model based on the MitchellSchaeffer model and a current dipole formulation. We validated our approach on a PVC localization (MDE = 20.3 mm), on 29 runs from 7 pacing sites by catheter (MDE = 21.6 mm) and on ten different pacing sequences from five CRT patients (MDE = 24.6 mm). A comparison with two standard inverse methods revealed that our personalization provides comparable results. We also showed that we were able to predict the response to biventricular pacings based on our personalized models with concordance in the BSPM signals. Finally, we showed on limited cases that personalized scar and myocardial geometry improved the results and we studied the extension of our method to standard 12-lead ECG data. This is an encouraging first step towards a preoperative prediction of different pacing conditions in order to assist clinicians for CRT decision and procedure.
